| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |